Published in Ann Surg on July 01, 2004
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg (2007) 3.73
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol (2006) 2.19
Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg (2006) 2.03
Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol (2010) 1.98
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality. Ann Surg (2006) 1.64
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg (2008) 1.60
Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg (2007) 1.58
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg (2005) 1.49
Current surgical treatment for bile duct cancer. World J Gastroenterol (2007) 1.30
Clinical significance of reconstruction of the right hepatic artery for biliary malignancy. Langenbecks Arch Surg (2006) 1.24
Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol (2008) 1.23
Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) (2009) 1.06
Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther (2011) 1.06
Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg (2009) 1.03
Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality. World J Surg (2014) 0.98
Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma. HPB (Oxford) (2009) 0.98
Management of perihilar cholangiocarcinoma in the era of multimodal therapy. Expert Rev Gastroenterol Hepatol (2012) 0.97
Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg (2014) 0.97
Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92
Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics. J Gastroenterol (2012) 0.92
Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol (2014) 0.90
Principles of surgical resection in hilar cholangiocarcinoma. World J Gastrointest Oncol (2013) 0.90
Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma. HPB (Oxford) (2013) 0.89
Cholangiocellular carcinoma--the role of caudate lobe resection and mesohepatectomy. HPB (Oxford) (2008) 0.89
Surgical resection for hilar cholangiocarcinoma: experience improves resectability. HPB (Oxford) (2011) 0.89
Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88
Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis (2014) 0.88
Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol (2013) 0.88
Value of Multidetector-row Computed Tomography in Diagnosis of Portal Vein Invasion by Perihilar Cholangiocarcinoma. World J Surg (2008) 0.88
Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case. Surg Today (2009) 0.87
Update on the management of cholangiocarcinoma. Dig Dis (2014) 0.87
Advances in diagnosis and treatment of hilar cholangiocarcinoma -- a review. Med Sci Monit (2013) 0.84
Survival benefit of hepatopancreatoduodenectomy for cholangiocarcinoma in comparison to hepatectomy or pancreatoduodenectomy. World J Surg (2010) 0.84
Surgical management of proximal bile duct cancers. Langenbecks Arch Surg (2012) 0.83
Therapeutical concepts and results for Klatskin tumors. Dtsch Arztebl Int (2008) 0.83
Radical surgery for right-sided klatskin tumor. HPB (Oxford) (2008) 0.83
Laparoscopy in the management of hilar cholangiocarcinoma. World J Gastroenterol (2014) 0.83
Intraoperative placement of external biliary drains for prevention and treatment of bile leaks after extended liver resection without bilioenteric anastomosis. World J Surg (2013) 0.83
The Clinical Usefulness of Simultaneous Placement of Double Endoscopic Nasobiliary Biliary Drainage. Clin Endosc (2015) 0.82
Portal vein resection using the no-touch technique with a hepatectomy for hilar cholangiocarcinoma. HPB (Oxford) (2013) 0.82
Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma. World J Surg (2013) 0.81
Clinicopathological analysis and prognosis of extrahepatic bile duct cancer with a microscopic positive ductal margin. HPB (Oxford) (2013) 0.81
Delay in surgical treatment of patients with hilar cholangiocarcinoma: does time impact outcomes? HPB (Oxford) (2013) 0.81
When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit (2014) 0.80
Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma. HPB Surg (2013) 0.80
One-stage resection for Bismuth type IV hilar cholangiocarcinoma with high hilar resection and parenchyma-preserving strategies: a cohort study. World J Surg (2013) 0.79
Flowcharts for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg (2008) 0.79
Evaluation of extra capsular lymph node involvement in patients with extra-hepatic bile duct cancer. World J Surg Oncol (2012) 0.78
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group. HPB (Oxford) (2014) 0.78
A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage. Gut Liver (2015) 0.78
Surgery for recurrent biliary carcinoma: results for 27 recurrent cases. World J Surg Oncol (2015) 0.78
The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg (2015) 0.78
Immunohistochemical Examination of a Resected Advanced Hilar Cholangiocarcinoma Arising in a 29-Year-Old Male without Primary Sclerosing Cholangitis. Case Rep Gastroenterol (2010) 0.77
Treatment of hilar cholangiocarcinoma of Bismuth-Corlette type III with hepaticojejunostomy. Contemp Oncol (Pozn) (2013) 0.77
Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. World J Surg (2016) 0.77
Duct-to-duct biliary reconstruction after radical resection of Bismuth IIIa hilar cholangiocarcinoma. World J Gastroenterol (2013) 0.77
Improving outcomes in cholangiocarcinomas. Gastrointest Cancer Res (2011) 0.76
Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution. Surg Today (2015) 0.76
Local surgical resection of hilar cholangiocarcinoma: is there still a place? HPB (Oxford) (2008) 0.76
Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand. World J Gastrointest Oncol (2015) 0.75
Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB (Oxford) (2016) 0.75
Left hepatic trisectionectomy for hilar cholangiocarcinoma presenting with an aberrant biliary duct of segment 5: a case report. J Med Case Rep (2010) 0.75
Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg (2016) 0.75
Lower incidence of complications in endoscopic nasobiliary drainage for hilar cholangiocarcinoma. World J Gastrointest Endosc (2016) 0.75
Extensively spreading intraepithelial bile duct carcinoma causing multiple bile duct strictures: report of three cases. Surg Today (2011) 0.75
Adjuvant gemcitabine monotherapy for resectable perihilar cholangiocarcinoma with lymph node involvement: a propensity score matching analysis. Surg Today (2016) 0.75
Isolated caudate lobectomy with pancreatoduodenectomy for a bile duct cancer. Langenbecks Arch Surg (2013) 0.75
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94
Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg (1996) 5.42
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Extended resections for hilar cholangiocarcinoma. Ann Surg (1999) 2.93
Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus. World J Surg (1990) 2.86
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg (2000) 2.55
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35
Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg (1988) 2.26
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol (1997) 2.16
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg (1998) 1.99
The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg (1998) 1.90
Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg (1999) 1.83
Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80
Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg (2000) 1.57
Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience. Surgery (2000) 1.55
Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg (2001) 1.44
One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg (2000) 1.40
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg (1999) 1.37
Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility. Surgery (2000) 1.34
Preoperative intrahepatic segmental cholangitis in patients with advanced carcinoma involving the hepatic hilus. Surgery (1996) 1.30
Technique of inserting multiple biliary drains and management. Hepatogastroenterology (1996) 1.19
Anatomy of the hepatic hilar area: the plate system. J Hepatobiliary Pancreat Surg (2000) 1.16
Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg (2002) 1.12
Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg (2000) 1.04
Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg (2002) 1.03
Study of the intrahepatic surgical margin of hilar bile duct carcinoma. Hepatogastroenterology (2002) 1.03
Surgery for hilar cholangiocarcinoma: an Italian experience. J Hepatobiliary Pancreat Surg (2000) 1.01
Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer. Br J Surg (2003) 0.97
Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg (2002) 0.97
Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology (2001) 0.93
Resection of hilar cholangiocarcinoma--a European and United States experience. J Hepatobiliary Pancreat Surg (2000) 0.91
Wedge resection of the portal bifurcation concomitant with left hepatectomy plus biliary reconstruction for hepatobiliary cancer. J Hepatobiliary Pancreat Surg (2002) 0.85
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med (2006) 4.18
Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell (2008) 2.69
Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A (2010) 2.52
CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas (2004) 2.48
Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics (2002) 2.47
Compact cysteine-coated CdSe(ZnCdS) quantum dots for in vivo applications. J Am Chem Soc (2007) 2.35
Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci (2012) 1.98
Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol (2010) 1.98
New invagination procedure for pancreaticojejunostomy using only four sutures. World J Surg (2012) 1.97
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg (2007) 1.83
CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res (2003) 1.83
In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J (2005) 1.80
Thirteen cases with intramural metastasis to the stomach in 1259 patients with oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg (2004) 1.79
Eap45 in mammalian ESCRT-II binds ubiquitin via a phosphoinositide-interacting GLUE domain. J Biol Chem (2005) 1.68
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment. J Hepatobiliary Pancreat Surg (2008) 1.60
Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system. Exp Cell Res (2004) 1.59
Efficacy and safety of artificial pneumothorax under two-lung ventilation in thoracoscopic esophagectomy for esophageal cancer in the prone position. Gen Thorac Cardiovasc Surg (2013) 1.55
Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas (2007) 1.54
Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer (2002) 1.54
Oncological benefit of preoperative endoscopic biliary drainage in patients with hilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci (2014) 1.49
Chest wall reconstruction using Gore-Tex® dual mesh. Ann Thorac Cardiovasc Surg (2011) 1.48
Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents. Surgery (2010) 1.45
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol (2003) 1.45
Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. Arthritis Rheum (2003) 1.40
Intraductal papillary-mucinous tumors arising in Santorini's duct: clinicopathologic features and the treatment of choice. World J Surg (2005) 1.39
Primary small-cell neuroendocrine carcinoma of the breast: report of a case. Surg Today (2008) 1.39
Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality. J Hepatobiliary Pancreat Sci (2009) 1.38
A new marking technique for peripheral lung nodules avoiding pleural puncture: the intrathoracic stamping method. Interact Cardiovasc Thorac Surg (2012) 1.36
Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys (2005) 1.36
Lung adenocarcinoma presenting with enlarged and multiloculated cystic lesions over 2 years. Respir Care (2004) 1.31
Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.30
Synthesis of conjugatable bisphosphonates for molecular imaging of large animals. Angew Chem Int Ed Engl (2007) 1.29
Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res (2004) 1.29
Real-time, near-infrared, fluorescence-guided identification of the ureters using methylene blue. Surgery (2010) 1.29
Localization and quantification of platelet-rich thrombi in large blood vessels with near-infrared fluorescence imaging. Circulation (2006) 1.28
Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One (2009) 1.28
Sox10-Venus mice: a new tool for real-time labeling of neural crest lineage cells and oligodendrocytes. Mol Brain (2010) 1.27
Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2010) 1.27
Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur J Neurosci (2005) 1.24
In vivo tracing of neural tracts in the intact and injured spinal cord of marmosets by diffusion tensor tractography. J Neurosci (2007) 1.22
Development of an automated large-scale protein-crystallization and monitoring system for high-throughput protein-structure analyses. Acta Crystallogr D Biol Crystallogr (2006) 1.22
Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep (2006) 1.19
Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr (2002) 1.19
Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep (2005) 1.18
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration (2003) 1.17
Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Cancer Res (2004) 1.15
Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer (2002) 1.15
Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification. Mol Imaging (2009) 1.14
Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res (2004) 1.14
Near-infrared fluorescence imaging of thoracic duct anatomy and function in open surgery and video-assisted thoracic surgery. J Thorac Cardiovasc Surg (2011) 1.14
Triclosan-coated sutures reduce the incidence of wound infections and the costs after colorectal surgery: a randomized controlled trial. Surgery (2012) 1.13
Early removal of drains and the incidence of seroma after breast surgery. Breast Cancer (2013) 1.13
Unilateral thoracoscopic subtotal thymectomy for the treatment of stage I and II thymoma. Eur J Cardiothorac Surg (2009) 1.13
Insufficient autophagy promotes bronchial epithelial cell senescence in chronic obstructive pulmonary disease. Oncoimmunology (2012) 1.12
Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Int J Oncol (2006) 1.12
A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer. Int J Radiat Oncol Biol Phys (2009) 1.11
Results of radical distal pancreatectomy with en bloc resection of the celiac artery for locally advanced cancer of the pancreatic body. Langenbecks Arch Surg (2003) 1.11
Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors. Int J Radiat Oncol Biol Phys (2005) 1.10
Solitary fibrous tumor of the pleura: MR appearance and enhancement pattern. J Comput Assist Tomogr (2002) 1.09
Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene (2003) 1.08
Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma. Surg Today (2005) 1.08
Successful resection of a recurrent mediastinal liposarcoma invading the pericardium: report of a case. Surg Today (2004) 1.07
Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab. Mod Rheumatol (2011) 1.06
Autoimmune pancreatitis associated with hemorrhagic pseudocysts: a case report and literature review. Intern Med (2008) 1.06
Successful laparoscopic right gastroepiploic aneurysmectomy: report of a case. Surg Today (2003) 1.06
Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiother Oncol (2003) 1.05
Importance of preoperative imaging with 64-row three-dimensional multidetector computed tomography for safer video-assisted thoracic surgery in lung cancer. Surg Today (2009) 1.05
Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2004) 1.05
Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol (2010) 1.05
Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study). Mod Rheumatol (2011) 1.04
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2013) 1.04
Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice. Pharmacogenet Genomics (2007) 1.04
Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response. J Surg Oncol (2003) 1.03
Role of radiotherapy for local control of asymptomatic adrenal metastasis from lung cancer. Am J Clin Oncol (2011) 1.03